Continuous Renal Replacement Therapy in Patients Treated with Extracorporeal Membrane Oxygenation

Overview

Journal Semin Dial

Specialty Nephrology

Date 2021 Mar 25

PMID 33765346

Citations 16

Authors

David T Selewski

Keith M Wille

Affiliations

Soon will be listed here.

Abstract

Extracorporeal membrane oxygenation (ECMO) is a life-saving therapy utilized for patients with severe life-threatening cardiorespiratory failure. Patients treated with ECMO are among the most severely ill encountered in critical care and are at high-risk of developing multiple organ dysfunction, including acute kidney injury (AKI) and fluid overload. Continuous renal replacement therapy (CRRT) is increasingly utilized inpatients on ECMO to manage AKI and treat fluid overload. The indications for renal replacement therapy for patients on ECMO are similar to those of other critically ill populations; however, there is wide practice variation in how renal supportive therapies are utilized during ECMO. For patients requiring both CRRT and ECMO, CRRT may be connected directly to the ECMO circuit, or CRRT and ECMO may be performed independently. This review will summarize current knowledge of the epidemiology of AKI, indications and timing of CRRT, delivery of CRRT, and the outcomes of patients requiring CRRT with ECMO.

Citing Articles

Risk factors for bloodstream infection in COVID-19 patients in intensive care units: a systematic review and meta-analysis.

Wang J, Jiang T BMC Infect Dis. 2025; 25(1):13.

PMID: 39754037 PMC: 11697680. DOI: 10.1186/s12879-024-10420-1.

Kidney Outcomes in Children Receiving Extracorporeal Membrane Oxygenation: A Single-Center Acute Cohort From 2009 to 2019, Followed to 2021.

Strong A, Makeneni S, Campos D, Fulchiero R, Kilbaugh T, Connelly J Pediatr Crit Care Med. 2024; 26(3):e287-e293.

PMID: 39660975 PMC: 11885026. DOI: 10.1097/PCC.0000000000003650.

Nutritional Intake in Venovenous ECMO Patients: A Single-Center Study in a North American PICU.

Lintvedt A, Purosky I, Kogelschatz B, Brackmann M, Heinze E, Parker J Nutrients. 2024; 16(22).

PMID: 39599600 PMC: 11597126. DOI: 10.3390/nu16223813.

Research progress on the pathogenesis of AKI complicated by ECMO.

Sun K, Yao C, Xu G, Wang J, Shou S, Jin H Clin Exp Nephrol. 2024; 29(1):10-20.

PMID: 39340702 PMC: 11807062. DOI: 10.1007/s10157-024-02559-7.

Efficacy of immediate versus delayed renal replacement therapy in septic patients undergoing continuous renal replacement therapy.

Ding G, Qiu P, Jin P, Xie Y, Zhang S, Lou Q Am J Transl Res. 2024; 16(8):3646-3653.

PMID: 39262694 PMC: 11384349. DOI: 10.62347/XSTK3213.

References

Thajudeen B, Kamel M, Arumugam C, Ali S, John S, Meister E . Outcome of patients on combined extracorporeal membrane oxygenation and continuous renal replacement therapy: a retrospective study. Int J Artif Organs. 2015; 38(3):133-7. DOI: 10.5301/ijao.5000381. View

Haneya A, Diez C, Philipp A, Bein T, Mueller T, Schmid C . Impact of Acute Kidney Injury on Outcome in Patients With Severe Acute Respiratory Failure Receiving Extracorporeal Membrane Oxygenation. Crit Care Med. 2015; 43(9):1898-906. DOI: 10.1097/CCM.0000000000001141. View

Wengenmayer T, Duerschmied D, Graf E, Chiabudini M, Benk C, Muhlschlegel S . Development and validation of a prognostic model for survival in patients treated with venoarterial extracorporeal membrane oxygenation: the PREDICT VA-ECMO score. Eur Heart J Acute Cardiovasc Care. 2018; 8(4):350-359. DOI: 10.1177/2048872618789052. View

Ryerson L, Balutis K, Granoski D, Nelson L, Patricia Massicotte M, Lequier L . Prospective Exploratory Experience With Bivalirudin Anticoagulation in Pediatric Extracorporeal Membrane Oxygenation. Pediatr Crit Care Med. 2020; 21(11):975-985. DOI: 10.1097/PCC.0000000000002527. View

Lee S, Yu M, Lee H, Ahn S, Kim S, Chin H . Risk Factors for Acute Kidney Injury and In-Hospital Mortality in Patients Receiving Extracorporeal Membrane Oxygenation. PLoS One. 2015; 10(10):e0140674. PMC: 4607159. DOI: 10.1371/journal.pone.0140674. View

Schmidt M, Zogheib E, Roze H, Repesse X, Lebreton G, Luyt C . The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. Intensive Care Med. 2013; 39(10):1704-13. PMC: 7094902. DOI: 10.1007/s00134-013-3037-2. View

Chen Y, Tsai F, Chang C, Lin C, Jenq C, Juan K . Prognosis of patients on extracorporeal membrane oxygenation: the impact of acute kidney injury on mortality. Ann Thorac Surg. 2010; 91(1):137-42. DOI: 10.1016/j.athoracsur.2010.08.063. View

Netley J, Roy J, Greenlee J, Hart S, Todt M, Statz B . Bivalirudin Anticoagulation Dosing Protocol for Extracorporeal Membrane Oxygenation: A Retrospective Review. J Extra Corpor Technol. 2018; 50(3):161-166. PMC: 6146270. View

McCanny P, Smith M, OBrien S, Buscher H, Carton E . Fluid Balance and Recovery of Native Lung Function in Adult Patients Supported by Venovenous Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy. ASAIO J. 2018; 65(6):614-619. DOI: 10.1097/MAT.0000000000000860. View

10.

Schmidt M, Burrell A, Roberts L, Bailey M, Sheldrake J, Rycus P . Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score. Eur Heart J. 2015; 36(33):2246-56. DOI: 10.1093/eurheartj/ehv194. View

11.

Bertini P, Guarracino F . Anticoagulation in extracorporeal membrane oxygenation: still a challenge. Minerva Anestesiol. 2019; 86(1):7-8. DOI: 10.23736/S0375-9393.19.14265-4. View

12.

Keckler S, Laituri C, Ostlie D, St Peter S . A review of venovenous and venoarterial extracorporeal membrane oxygenation in neonates and children. Eur J Pediatr Surg. 2009; 20(1):1-4. DOI: 10.1055/s-0029-1231053. View

13.

Hoover N, Heard M, Reid C, Wagoner S, Rogers K, Foland J . Enhanced fluid management with continuous venovenous hemofiltration in pediatric respiratory failure patients receiving extracorporeal membrane oxygenation support. Intensive Care Med. 2008; 34(12):2241-7. DOI: 10.1007/s00134-008-1200-y. View

14.

Nentwich J, Wichmann D, Kluge S, Lindau S, Mutlak H, John S . Low-flow CO removal in combination with renal replacement therapy effectively reduces ventilation requirements in hypercapnic patients: a pilot study. Ann Intensive Care. 2019; 9(1):3. PMC: 6323065. DOI: 10.1186/s13613-019-0480-4. View

15.

Zhong H, Zhu M, Yu Y, Li W, Xing S, Zhao X . Management of Bivalirudin Anticoagulation Therapy for Extracorporeal Membrane Oxygenation in Heparin-Induced Thrombocytopenia: A Case Report and a Systematic Review. Front Pharmacol. 2020; 11:565013. PMC: 7516194. DOI: 10.3389/fphar.2020.565013. View

16.

Devasagayaraj R, Cavarocchi N, Hirose H . Does acute kidney injury affect survival in adults with acute respiratory distress syndrome requiring extracorporeal membrane oxygenation?. Perfusion. 2018; 33(5):375-382. DOI: 10.1177/0267659118755272. View

17.

Muller G, Flecher E, Lebreton G, Luyt C, Trouillet J, Brechot N . The ENCOURAGE mortality risk score and analysis of long-term outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock. Intensive Care Med. 2016; 42(3):370-378. DOI: 10.1007/s00134-016-4223-9. View

18.

Kaseer H, Soto-Arenall M, Sanghavi D, Moss J, Ratzlaff R, Pham S . Heparin vs bivalirudin anticoagulation for extracorporeal membrane oxygenation. J Card Surg. 2020; 35(4):779-786. DOI: 10.1111/jocs.14458. View

19.

Smith A, Hardison D, Worden C, Fleming G, Taylor M . Acute renal failure during extracorporeal support in the pediatric cardiac patient. ASAIO J. 2009; 55(4):412-6. DOI: 10.1097/MAT.0b013e31819ca3d0. View

20.

Tsai T, Chien H, Tsai F, Pan H, Yang H, Lee S . Comparison of RIFLE, AKIN, and KDIGO classifications for assessing prognosis of patients on extracorporeal membrane oxygenation. J Formos Med Assoc. 2017; 116(11):844-851. DOI: 10.1016/j.jfma.2017.08.004. View